Cardiff Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	17.47	51.47	21.66	16.35	11.94
Short-Term Investments	40.83	40.28	53.17	88.92	128.88
Cash & Short-Term Investments	58.3	91.75	74.82	105.27	140.82
Cash Growth	-36.45%	22.62%	-28.92%	-25.25%	7.51%
Accounts Receivable	0.18	0.77	0.29	0.77	0.54
Other Current Assets	1.64	2.54	2.3	5.25	4.77
Total Current Assets	60.13	95.05	77.41	111.28	146.13
Net Property, Plant & Equipment	1.21	2.07	2.95	3.52	3.18
Other Long-Term Assets	0.55	0.07	1.28	1.39	0.24
Total Assets	61.88	97.19	81.64	116.19	149.54
Accounts Payable	8.09	4.82	1.97	1.96	1.44
Accrued Expenses	7.58	7.9	7.78	5.18	4.53
Current Portion of Leases	0.73	0.71	0.69	0.68	0.55
Other Current Liabilities	-	-	-	-	0.04
Total Current Liabilities	16.39	13.43	10.44	7.81	6.56
Long-Term Leases	0.1	0.81	1.46	2.04	2.57
Total Long-Term Liabilities	0.1	0.81	1.46	2.04	2.57
Total Liabilities	16.5	14.24	11.9	9.85	9.13
Preferred Stock	-	-	-	-	0
Common Stock	0.01	0.01	0	0	0
Additional Paid-in Capital	475.36	467.09	409.34	404.83	400.5
Accumulated Other Comprehensive Income	0.05	0.03	-0.07	-0.4	-0.14
Retained Earnings	-430.03	-384.18	-339.54	-298.1	-259.81
Shareholders' Equity	45.39	82.95	69.74	106.34	140.42
Total Liabilities & Equity	61.88	97.19	81.64	116.19	149.54
Total Debt	0.83	1.52	2.15	2.72	3.12
Net Cash (Debt)	57.47	90.22	72.67	102.55	137.7
Net Cash Growth	-36.30%	24.15%	-29.13%	-25.53%	5.83%
Net Cash Per Share	0.86	1.89	1.63	2.35	3.53
Book Value	45.39	82.95	69.74	106.34	140.42
Book Value Per Share	0.68	1.74	1.56	2.44	3.60
Tangible Book Value	45.39	82.95	69.74	106.34	140.42
Tangible Book Value Per Share	0.68	1.74	1.56	2.44	3.60

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q